Abstract
In a large, contemporary cohort of ambulatory patients with atrial fibrillation who received care within a health maintenance organization, warfarin use was considerably higher than in other reported studies. Although the reasons why physicians did not prescribe warfarin could not be elucidated, many apparently eligible patients with atrial fibrillation and at least one additional risk factor for stroke, especially hypertension, did not receive anticoagulation. Interventions are needed to increase the use of warfarin for stroke prevention among appropriate candidates.
Keywords
Atrial fibrillationMedicineWarfarinOdds ratioAmbulatoryStroke (engine)Internal medicineCardiologyAnticoagulantCohort
Affiliated Institutions
Related Publications
Worldwide Epidemiology of Atrial Fibrillation
Background— The global burden of atrial fibrillation (AF) is unknown. Methods and Results— We systematically reviewed population-based studies of AF published from 1980 to 2010 ...
Lifetime Risk for Development of Atrial Fibrillation
Background— Atrial fibrillation (AF) is the most common cardiac dysrhythmia and a source of considerable morbidity and mortality, but lifetime risk for AF has not been estimated...
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
In this prospective study in a European population, the prevalence and incidence of AF increased with age and were higher in men than in women. The high lifetime risk to develop...
A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation Recurrence
Background— Intermittent rhythm monitoring (IRM) to detect atrial fibrillation (AF) recurrence is employed to evaluate the success of therapeutic interventions. In a large popul...
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
We estimate that from 2010 to 2060, the number of adults 55 years and over with AF in the European Union will more than double. As AF is associated with significant morbidities ...
Publication Info
- Year
- 1999
- Type
- article
- Volume
- 131
- Issue
- 12
- Pages
- 927-934
- Citations
- 587
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
587
OpenAlex
Cite This
Alan S. Go,
Elaine M. Hylek,
Leila H. Borowsky
et al.
(1999).
Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Annals of Internal Medicine
, 131
(12)
, 927-934.
https://doi.org/10.7326/0003-4819-131-12-199912210-00004
Identifiers
- DOI
- 10.7326/0003-4819-131-12-199912210-00004